89Bio Inc expected to post a loss of 46 cents a share - Earnings Preview

89bio

30/04/2024 12:38

* 89Bio Inc  ETNB.OQ   ETNB.O  is expected to show no change
in
quarterly revenue when it reports  results on May 2 (estimated)
for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for 89Bio Inc is for a loss
of 46
cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 0.5%
in the last three months. ​
    * Wall Street's median 12-month price target for 89Bio Inc
is
$31.00​, above​ its last closing price of $8.53. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.48       -0.49      -0.50     Missed  -1
 Sep. 30 2023  -0.53       -0.53      -0.45     Beat    15.1
 Jun. 30 2023  -0.42       -0.41      -0.52     Missed  -26.4​
 Mar. 31 2023  -0.48       -0.52      -0.54     Missed  -3.5
 ​​Dec.        -0.68       -0.69      -0.48     Beat    30.1
 31 2022                                                
 Sep. 30 2022  -0.82       -0.80      -0.57     Beat    28.5​
 Jun. 30 2022  -1.04       -1.05      -1.23     Missed  -16.8
 Mar. 31 2022  -1.32       -1.29      -1.26     Beat    2.5
 This summary was machine generated April 30 at 11:38 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)